These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 6390255

  • 1. [Update on antibiotic therapy. 27) Ceftazidime].
    di Nola F.
    Minerva Med; 1984 Oct 06; 75(38):2253-61. PubMed ID: 6390255
    [No Abstract] [Full Text] [Related]

  • 2. [Update on antibiotic therapy. 30) Cefonicid].
    di Nola F.
    Minerva Med; 1985 Apr 14; 76(16):819-25. PubMed ID: 4000526
    [No Abstract] [Full Text] [Related]

  • 3. [Update on antibiotic therapy. 2) Rifampicin].
    Di Nola F.
    Minerva Med; 1982 Feb 25; 73(7):357-62. PubMed ID: 7188493
    [No Abstract] [Full Text] [Related]

  • 4. [Update on antibiotic therapy. 10) Cefaclor].
    Di Nola F.
    Minerva Med; 1982 Oct 06; 73(38):2629-32. PubMed ID: 6821380
    [No Abstract] [Full Text] [Related]

  • 5. [Update on antibiotic therapy. 18) Lincomycin].
    Di Nola F.
    Minerva Med; 1983 Jun 16; 74(25):1511-6. PubMed ID: 6431333
    [No Abstract] [Full Text] [Related]

  • 6. [Update on antibiotic therapy. 3) Josamycin].
    Di Nola F.
    Minerva Med; 1982 Mar 17; 73(11):621-4. PubMed ID: 7188491
    [No Abstract] [Full Text] [Related]

  • 7. [Update on antibiotic therapy. 19) Cefotetan].
    Di Nola F.
    Minerva Med; 1983 Nov 10; 74(43):2653-8. PubMed ID: 6379515
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
    Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE.
    J Antimicrob Chemother; 2005 Jan 10; 55(1):90-4. PubMed ID: 15574481
    [Abstract] [Full Text] [Related]

  • 9. [Antimicrobial activity of ceftazidime and its pharmacokinetics in patients with renal failure].
    Skala LZ, Nasonov VN, Cherniakov VL, Nekhorosheva AG, Prokhorova VA.
    Antibiot Khimioter; 1991 May 10; 36(5):33-6. PubMed ID: 1953171
    [Abstract] [Full Text] [Related]

  • 10. [Update on antibiotic therapy. 6) Amikacin].
    Di Nola F.
    Minerva Med; 1982 Jun 08; 73(24):1749-54. PubMed ID: 7188492
    [No Abstract] [Full Text] [Related]

  • 11. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C, Sirham M, Labarca J, Grebe G, Lira P, Oliva J, Duhalde M, Ocqueteau M, Acuña G.
    Rev Med Chil; 1995 Mar 08; 123(3):312-20. PubMed ID: 8525170
    [Abstract] [Full Text] [Related]

  • 12. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR, Therese KL, Madhavan HN.
    Indian J Ophthalmol; 2000 Jun 08; 48(2):123-8. PubMed ID: 11116508
    [Abstract] [Full Text] [Related]

  • 13. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece.
    Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A.
    Int J Antimicrob Agents; 2007 Oct 08; 30(4):360-5. PubMed ID: 17629680
    [Abstract] [Full Text] [Related]

  • 14. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D, Rubowitz A, Assia E.
    Orbit; 2005 Mar 08; 24(1):29-32. PubMed ID: 15764113
    [Abstract] [Full Text] [Related]

  • 15. [Ceftazidime: review of the microbiological and clinical experience].
    Arosio E, Pancera P, Montesi G.
    Recenti Prog Med; 1985 Dec 08; 76(12):635-42. PubMed ID: 3914016
    [No Abstract] [Full Text] [Related]

  • 16. [Microorganisms isolated from middle ear cultures and their antibacterial susceptibility in patients with chronic suppurative otitis media].
    Gül HC, Kurnaz A, Turhan V, Oncül O, Pahsa A.
    Kulak Burun Bogaz Ihtis Derg; 2006 Dec 08; 16(4):164-8. PubMed ID: 16905907
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2008 Feb 08; 61(2):371-4. PubMed ID: 18033780
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of sensitivity of different organisms to cefepime and tazobactum (megapime XP) in comparison to cefepime and ceftazidime.
    Pal RB, Pal P, Venkatesh V, Kulkarni KP.
    J Indian Med Assoc; 2008 Sep 08; 106(9):605-6, 611. PubMed ID: 19552092
    [Abstract] [Full Text] [Related]

  • 19. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA, Rossolini GM.
    Expert Rev Anti Infect Ther; 2008 Oct 08; 6(5):549-50. PubMed ID: 18847392
    [No Abstract] [Full Text] [Related]

  • 20. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M, Kokuno M, Suzuki Y, Iwama M, Shindo M, Uchida Y.
    J Antibiot (Tokyo); 2008 Jan 08; 61(1):33-5. PubMed ID: 18305357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.